Form 8-K - Current report:
SEC Accession No. 0000950170-25-081604
Filing Date
2025-06-04
Accepted
2025-06-04 16:05:23
Documents
20
Period of Report
2025-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20250528.htm   iXBRL 8-K 71184
2 EX-4.1 revb-ex4_1.htm EX-4.1 193064
3 EX-4.2 revb-ex4_2.htm EX-4.2 164578
4 EX-4.3 revb-ex4_3.htm EX-4.3 219909
5 EX-10.1 revb-ex10_1.htm EX-10.1 160599
6 EX-10.2 revb-ex10_2.htm EX-10.2 350289
7 EX-99.1 revb-ex99_1.htm EX-99.1 21756
8 EX-99.2 revb-ex99_2.htm EX-99.2 21978
9 GRAPHIC img220778470_0.jpg GRAPHIC 19195
10 GRAPHIC img221701991_0.jpg GRAPHIC 19195
11 GRAPHIC img251863448_0.jpg GRAPHIC 987
  Complete submission text file 0000950170-25-081604.txt   1586260

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20250528.xsd EX-101.SCH 47760
22 EXTRACTED XBRL INSTANCE DOCUMENT revb-20250528_htm.xml XML 6769
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 251023124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)